Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity.
Abstract
Copyright © 2014. Published by Elsevier Inc.
KEYWORDS:
(2-AG), (AEA), (AM-251), (AM-630), (CB1), (CB2), (FR180204), (IRAK1BP1), (Ly294002), (MKP-1), (MKP-2), (Ro-318220), (SB203580), (SP600125), (TTP), (U0126), 1,4-Diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene), 2(MAP-2), 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-onehydrochloride), 2-arachidonoylglycerol, 3-[3-[2,5-Dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl carbamimidothioic acid ester mesylate), 4-[5-(4-Fluorophenyl)-2-[4 (methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine), 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine), 6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone), Anthra[1-9-cd]pyrazol-6(2H)-one), Cannabinoid receptor type 1, Cannabinoid receptor type 2, HIV1 Tat, IL-1R-associated kinase 1 binding protein 1, Microtubule-associated protein, Mitogen-activated protein kinase phosphatase-1, Muller glia, N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3 carboxamide, N-arachidonoylethanolamide, Tristetraprolin, endocannabinoids, mitogen-activated protein kinase phosphatase-2, retina
- PMID:
24418364
[PubMed – as supplied by publisher]